HCMV INFECTION: MODULATING THE CELL CYCLE AND CELL DEATH

REFERENCES

• J.E.S., Mocarski, C. T., Courcelle. Cytomegaloviruses and their replication. Fields Virology, 4th ed., D. M., Knipe, P. M., Howley, Philadelphia, PA, Lipplncott Williams & Wilkins. 2629–2673, 2001
   Google Scholar
• R. F., Pass. Cytomegalovirus. Fields Virology, 4th ed., D. M., Knipe, P. M., Howley, Philadelphia, PA, Lippincott Williams & Wilkins. 2575–2705, 2001
   Google Scholar
• M., Ho. Cytomegalovirus: Biology & Infection. New York, Plenum Medical Book Company. 1982
   Google Scholar
• I., Boldogh, E., Gonczol, L., Vaczi. Transformation of hamster embryonic fibroblast cells by UV-irradiated human cytomegalovirus. Acta Microbiol. Acad. Sci. Hung.. 25: 269–275, 1978
   Google Scholar
• T., Albrecht, F., Rapp. Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology. 55: 53–61, 1973, [CROSSREF]
   PubMedGoogle Scholar
• K. M., Geder, R., Lausch, F., O'Neill, F., Rapp. Oncogenic transformation of human embryo lung cells by human cytomegalovirus. Science. 192: 1134–1137, 1976
   PubMed Web of Science ®Google Scholar
• C. Y., Shen, M. S., Ho, S. F., Chang, M. S., Yen, H. T., Ng, E. S., Huang, C. W., Wu. High rate of concurrent genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients. J. Infect. Dis.. 168: 449–452, 1993
   Google Scholar
• J., Doniger, S., Muralidhar, L. J., Rosenthal. Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clin. Microbiol. Rev.. 12: 367–382, 1999, [CSA]
   PubMed Web of Science ®Google Scholar
• D. M., Lukac, J. C., Alwine. Effects of human cytomegalovirus major immediate-early proteins in controlling the cell cycle and inhibiting apoptosis: Studies with ts13 cells. J. Virol.. 73: 2825–2831, 1999, [CSA]
   Google Scholar
• Y., Shen, H., Zhu, T., Shenk. Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate “hit-and-run” oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc. Natl. Acad. Sci. USA. 94: 3341–3345, 1997, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• E., Speir, E. S., Huang, R., Modali, M. B., Leon, F., Shawl, T., Finkel, S. E., Epstein. Interaction of human cytomegalovirus with p53: Possible role in coronary restenosis. Scand. J. Infect. Dis. Suppl.. 99: 78–81, 1995, [CSA]
   Google Scholar
• E., Speir, R., Modali, E. S., Huang, M. B., Leon, F., Shawl, T., Finkel, S. E., Epstein. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 265: 391–394, 1994
   PubMed Web of Science ®Google Scholar
• Y. F., Zhou, M. B., Leon, M. A., Waclawiw, J. J., Popma, Z. X., Yu, T., Finkel, S. E., Epstein. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med.. 335: 624–630, 1996, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Y. F., Zhou, Z. X., Yu, C., Wanishsawad, M., Shou, S. E., Epstein. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor. Biochem. Biophys. Res. Commun.. 256: 608–613, 1999, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S., Michelson, P., Dal Monte, D., Zipeto, B., Bodaghi, L., Laurent, E., Oberlin, F., Arenzana-Seisdedos, J. L., Virelizier, M. P., Landini. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J. Virol.. 71: 6495–6500, 1997, [CSA]
   PubMed Web of Science ®Google Scholar
• G., Steinhoff, X. M., You, C., Steinmuller, K., Boeke, F. S., Stals, C. A., Bruggeman, A., Haverich. Induction of endothelial adhesion molecules by rat cytomegalovirus in allogeneic lung transplantation in the rat. Scand. J. Infect. Dis. Suppl.. 99: 58–60, 1995, [CSA]
   Google Scholar
• D. N., Streblow, C., Soderberg-Naucler, J., Vieira, P., Smith, E., Wakabayashi, F., Ruchti, K., Mattison, Y., Altschuler, J. A., Nelson. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell. 99: 511–520, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• T., Albrecht, M., Nachtigal, S. C., St Jeor, F., Rapp. Induction of cellular DNA synthesis and increased mitotic activity in syrian hamster embryo cells abortively infected with human cytomegalovirus. J. Gen. Virol.. 30: 167–177, 1976
   PubMedGoogle Scholar
• E., Gonczol, S. A., Plotkin. Cells infected with human cytomegalovirus release a factor(s) that stimulates cell DNA synthesis. J. Gen. Virol.. 65(Pt 10)1833–1837, 1984
   Google Scholar
• S. C., St. Jeor, T. B., Albrecht, F. D., Funk, F., Rapp. Stimulation of cellular DNA Synthesis by Human Cytomegalovirus. J. Virol.. 13: 353–362; 1974
   Google Scholar
• E., Speir, Z. X., Yu, K., Takeda, V. J., Ferrans, R. O., 3rd. Cannon. Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells. Circulation. 102: 2990–2996, 2000
   Google Scholar
• H., Zhu, Y., Shen, T., Shenk. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol.. 69: 7960–7970, 1995, [CSA]
   PubMedGoogle Scholar
• F. M., Jault, J. M., Jault, F., Ruchti, E. A., Fortunato, C., Clark, J., Corbeil, D. D., Richman, D. H., Spector. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J. Virol.. 69: 6697–6704, 1995, [CSA]
   Google Scholar
• M., Lu, T., Shenk. Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J. Virol.. 70: 8850–8857, 1996, [CSA]
   PubMedGoogle Scholar
• D., Dittmer, E. S., Mocarski. Human cytomegalovirus infection inhibits G1/S transition. J. Virol.. 71: 1629–1634, 1997, [CSA]
   Google Scholar
• W. A., Bresnahan, I., Boldogh, E. A., Thompson, T., Albrecht. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology. 224: 150–160, 1996, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. R., Nevins. Cell transformation by viruses. Fields Virology, 4th ed., D. M., Knipe, P. M., Howley, Philadelphia, PA, Lippincott Williams & Wilkins. 245–283, 2001
   Google Scholar
• J. W., Harbour, D. C., Dean. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes. Dev.. 14: 2393–2409, 2000, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. M., Trimarchi, J. A., Lees. Transcriptionsibling rivalry in the E2f family. Nat. Rev. Mol. Cell. Biol.. 3: 11–20, 2002, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. R., Nevins. Toward an understanding of the functional complexity of the e2F and retinoblastoma families. Cell Growth Differ.. 9: 585–593, 1998, [CSA]
   PubMedGoogle Scholar
• J., DeGregori, T. F., Kowalik, J. R., Nevins. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis and G1/S regulatory genes. Mol. Cell. Biol.. 15: 4215–4224, 1995
   PubMed Web of Science ®Google Scholar
• T., Kowalik, J., DeGregori, J. K., Schwarz, J. R., Nevins. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol.. 69: 2491–2500, 1995, [CSA]
   PubMedGoogle Scholar
• C., Prives, P. A., Hall. The p53 pathway. J. Pathol.. 187: 112–126, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. W., Harper, G. R., Adami, N., Wei, K., Keyomarsi, S. J., Elledge. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin- dependent kinases. Cell. 75: 805–816, 1993, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W. S., el-Deiry, T., Tokino, V. E., Velculescu, D. B., Levy, R., Parsons, J. M., Trent, D., Lin, W. E., Mercer, K. W., Kinzler, B., Vogelstein. WAF1, a potential mediator of p53 tumor suppression. Cell. 75: 817–825, 1993, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P., Sarnow, Y. S., Ho, J., Williams, A. J., Levine. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell. 28: 387–394, 1982, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J., Bargonetti, I., Reynisdottir, P. N., Friedman, C., Prives. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes. Dev.. 6: 1886–1898, 1992
   PubMed Web of Science ®Google Scholar
• S. W., Lowe, H. E., Ruley. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes. Dev.. 7: 535–545, 1993
   PubMed Web of Science ®Google Scholar
• S. A., McCarthy, H. S., Symonds, T., Van. Dyke, Regulation of apoptosis in transgenic mice by simian virus 40 T antigen- mediated inactivation of p53. Proc. Natl. Acad. Sci. USA. 91: 3979–3983, 1994, [CSA]
   PubMed Web of Science ®Google Scholar
• P. R., Yew, A. J., Berk. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature. 357: 82–85, 1992, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Scheffner, B. A., Werness, J. M., Huibregtse, A. J., Levine, P. M., Howley. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63: 1129–1136, 1990, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• D., Johnson, J. K., Schwarz, W. D., Cress, J. R., Nevins. Expression of transcription factor E2F1 induces quiescent cells to enter S-phase. Nature. 378: 206–208, 1993, [CROSSREF]
   Google Scholar
• J., Sinclair, J., Baillie, L., Bryant, R., Caswell. Human cytomegalovirus mediates cell cycle progression through G(1) into early S phase in terminally differentiated cells. J. Gen. Virol.. 81(Pt 6)1553–1565, 2000, [CSA]
   Google Scholar
• B., Ruger, S., Klages, B., Walla, J., Albrecht, B., Fleckenstein, P., Tomlinson, B., Barrell. Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. J. Virol.. 61: 446–453, 1987, [CSA]
   PubMed Web of Science ®Google Scholar
• C., Roby, W., Gibson. Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus. J. Virol.. 59: 714–727, 1986, [CSA]
   Google Scholar
• G. M., Hensel, H. H., Meyer, I., Buchmann, D., Pommerehne, S., Schmolke, B., Plachter, K., Radsak, H. F., Kern. Intracellular localization and expression of the human cytomegalovirus matrix phosphoprotein pp71 (ppUL82): Evidence for its translocation into the nucleus. J. Gen. Virol.. 77: 3087–3097, 1996, [CSA]
   Google Scholar
• W. A., Bresnahan, T. E., Shenk. UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc. Natl. Acad. Sci. USA. 97: 14506–14511, 2000, [CSA], [CROSSREF]
   Google Scholar
• R. F., Kalejta, J. T., Bechtel, T., Shenk. Mutations that abolish the ability of HCMV pp71 protein to induce DNA synthesis in quiescent cells do not affect its ability to accelerate G1 phase cell cycle progression. J. Virol.. 77: 3451–3459, 2003, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• R. F., Kalejta, T., Shenk, The HCMV. Protein pp71 Induces DNA synthesis in quiescent cells by targeting members of the RB family of tumor suppressor for degradation. Mol. Cell. Biol.. 23: 1885–1895, 2003, [CROSSREF]
   PubMedGoogle Scholar
• R. F., Kalejta, T., Shenk. Manipulation of the cell cycle by human cytomegalovirus. Front. Biosci.. 7: d295–306, 2002, [CSA]
   PubMedGoogle Scholar
• M. F., Stinski, D. R., Thomsen, R. M., Stenberg, L. C., Goldstein. Organization and expression of the immediate early genes of human cytomegalovirus. J. Virol.. 46: 1–14, 1983, [CSA]
   PubMedGoogle Scholar
• R. F., Greaves, E. S., Mocarski. Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J. Virol.. 72: 366–379, 1998, [CSA]
   PubMedGoogle Scholar
• A. C., Iskenderian, L., Huang, A., Reilly, R. M., Stenberg, D. G., Anders. Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes. J. Virol.. 70: 383–392, 1996, [CSA]
   Google Scholar
• R. A., Johnson, A. D., Yurochko, E. E., Poma, L., Zhu, E. S., Huang. Domain mapping of the human cytomegalovirus IE1-72 and cellular p107 protein-protein interaction and the possible functional consequences. J. Gen. Virol.. 80: 1293–1303, 1999, [CSA]
   Google Scholar
• E. E., Poma, T. F., Kowalik, L., Zhu, J. H., Sinclair, E. S., Huang. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J. Virol.. 70: 7867–7877, 1996, [CSA]
   PubMedGoogle Scholar
• M. J., Margolis, S., Pajovic, E. L., Wong, M., Wade, R., Jupp, J. A., Nelson, J. C., Azizkhan. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J. Virol.. 69: 7759–7767, 1995, [CSA]
   PubMedGoogle Scholar
• G. P., Hayhurst, L. A., Bryant, R. C., Caswell, S. M., Walker, J. H., Sinclair. CCAAT box-dependent activation of the TATA-less human DNA polymerase alpha promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein. J. Virol.. 69: 182–188, 1995, [CSA]
   PubMedGoogle Scholar
• S., Pajovic, E. L., Wong, A. R., Black, J. C., Azizkhan. Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins. Mol. Cell. Biol.. 17: 6459–6464, 1997
   PubMedGoogle Scholar
• L., Zhu, S., van den Heuvel, K., Helin, A., Fattaey, M., Ewen, D., Livingston, N., Dyson, E., Harlow. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev.. 7: 1111–1125, 1993
   PubMed Web of Science ®Google Scholar
• J. P., Castillo, H. A., Rogoff, T. F., Kowalik. HCMV IE1-72 induces p53 through multiple pathways to induce a growth arrest response, (submitted for publication). 2003
   Google Scholar
• J. P., Castillo, A. D., Yurochko, T. F., Kowalik. Role of human cytomegalovirus immediate-early proteins in cell growth control. J. Virol.. 74: 8028–8037, 2000, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• A., Marchini, H., Liu, H., Zhu. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol.. 75: 1870–1878, 2001, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C., Hagemeier, R., Caswell, G., Hayhurst, J., Sinclair, T., Kouzarides. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J.. 13: 2897–2903, 1994, [CSA]
   PubMedGoogle Scholar
• E. A., Fortunato, M. H., Sommer, K., Yoder, D. H., Spector. Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other. J. Virol.. 71: 8176–8185, 1997, [CSA]
   PubMedGoogle Scholar
• Y., Song, M. F., Stinkski. Effect of the human cytomegalovirus IE86 protein on expression of E2F responsive genes: A DNA microarray analysis. Proc. Natl. Acad. Sci. USA. 99: 2836–2841, 2002, [CSA]
   PubMedGoogle Scholar
• E. A., Murphy, D. N., Streblow, J. A., Nelson, M. F., Stinski. The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J. Virol.. 74: 7108–7118, 2000, [CSA], [CROSSREF]
   Google Scholar
• W. A., Bresnahan, T., Albrecht, E. A., Thompson. The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J. Biol. Chem.. 273: 22075–22082, 1998, [CROSSREF]
   Google Scholar
• H. L., Tsai, G. H., Kou, S. C., Chen, C. W., Wu, Y. S., Lin. Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. J. Biol. Chem.. 271: 3534–3540, 1996, [CROSSREF]
   Google Scholar
• M., Winkler, S. A., Rice, T., Stamminger. UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J. Virol.. 68: 3943–3954, 1994, [CSA]
   PubMedGoogle Scholar
• M., Winkler, T., Stamminger. A specific subform of the human cytomegalovirus transactivator protein pUL69 is contained within the tegument of virus particles. J. Virol.. 70: 8984–8987, 1996, [CSA]
   PubMedGoogle Scholar
• M., Winkler, T., aus Dem Siepen, T., Stamminger. Functional interaction between pleiotropic transactivator pUL69 of human cytomegalovirus and the human homolog of yeast chromatin regulatory protein SPT6. J. Virol.. 74: 8053–8064, 2000, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• M., Lu, T., Shenk. Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle. J. Virol.. 73: 676–683, 1999, [CSA]
   PubMedGoogle Scholar
• M. L., Hayashi, C., Blankenship, T., Shenk. Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proc. Natl. Acad. Sci. USA. 97: 2692–2696, 2000, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• K. L., McQueen, P., Parham. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol.. 14: 615–621, 2002, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• T. R., Jones, E. J., Wiertz, L., Sun, K. N., Fish, J. A., Nelson, H. L., Ploegh. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA. 93: 11327–11333, 1996, [CSA], [CROSSREF]
   Google Scholar
• K., Ahn, A., Angulo, P., Ghazal, P. A., Peterson, Y., Yang, K., Fruh. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA. 93: 10990–10995, 1996, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S., Lee, J., Yoon, B., Park, Y., Jun, M., Jin, H. C., Sung, I. H., Kim, S., Kang, E. J., Choi, B. Y., Ahn, K., Ahn. Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules. J. Virol.. 74: 11262–11269, 2000, [CSA], [CROSSREF]
   Google Scholar
• A. T., Bankier, S., Beck, R., Bohni, C. M., Brown, R., Cerny, M. S., Chee, C. A., Hutchison, 3rd, T., Kouzarides, J. A., Martignetti, E., Preddie, et al, The DNA sequence of the human cytomegalovirus genome. DNA Seq.. 2: 1–12, 1991
   PubMedGoogle Scholar
• E. J., Wiertz, D., Tortorella, M., Bogyo, J., Yu, W., Mothes, T. R., Jones, T. A., Rapoport, H. L., Ploegh. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature. 384: 432–438, 1996, [CROSSREF]
   PubMedGoogle Scholar
• D., Tortorella, C. M., Story, J. B., Huppa, E. J., Wiertz, T. R., Jones, I., Bacik, J. R., Bennink, J. W., Yewdell, H. L., Ploegh. Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential. J. Cell. Biol.. 142: 365–376, 1998, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C. M., Story, M. H., Furman, H. L., Ploegh. The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products. Proc. Natl. Acad. Sci. USA. 96: 8516–8521, 1999, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• M. H., Furman, H. L., Ploegh, D., Tortorella. Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules. J. Biol. Chem.. 277: 3258–3267, 2002, [CROSSREF]
   Google Scholar
• D. J., Schust, D., Tortorella, J., Seebach, C., Phan, H. L., Ploegh. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med.. 188: 497–503, 1998, [CROSSREF]
   Google Scholar
• E. A., Hughes, C., Hammond, P., Cresswell. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA. 94: 1896–1901, 1997, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H., Hengel, T., Flohr, G. J., Hammerling, U. H., Koszinowski, F., Momburg. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J. Gen. Virol.. 77(Pt 9)2287–2296, 1996
   Google Scholar
• P. J., Lehner, J. T., Karttunen, G. W., Wilkinson, P., Cresswell. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA. 94: 6904–6909, 1997, [CSA], [CROSSREF]
   Google Scholar
• K., Ahn, A., Gruhler, B., Galocha, T. R., Jones, E. J., Wiertz, H. L., Ploegh, P. A., Peterson, Y., Yang, K., Fruh. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 6: 613–621, 1997, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• E. W., Hewitt, S. S., Gupta, P. J., Lehner. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J.. 20: 387–396, 2001, [CSA], [CROSSREF]
   Google Scholar
• C., Kyritsis, S., Gorbulev, S., Hutschenreiter, K., Pawlitschko, R., Abele, R., Tampe. Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6. J. Biol. Chem.. 276: 48031–48039, 2001
   Google Scholar
• L. K., Borysiewicz, J. K., Hickling, S., Graham, J., Sinclair, M. P., Cranage, G. L., Smith, J. G., Sissons. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J. Exp. Med.. 168: 919–931, 1988, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M. J., Gilbert, S. R., Riddell, B., Plachter, P. D., Greenberg. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature. 383: 720–722, 1996, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H., Browne, M., Churcher, T., Minson. Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted. J. Virol.. 66: 6784–6787, 1992, [CSA]
   Google Scholar
• T. L., Chapman, A. P., Heikeman, P. J., Bjorkman. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity. 11: 603–613, 1999, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• D., Cosman, N., Fanger, L., Borges, M., Kubin, W., Chin, L., Peterson, M. L., Hsu. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 7: 273–282, 1997, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Vitale, R., Castriconi, S., Parolini, D., Pende, M. L., Hsu, L., Moretta, D., Cosman, A., Moretta. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: Analysis of LIR-1 + NK cell clones. Int. Immunol.. 11: 29–35, 1999, [CROSSREF]
   Google Scholar
• H. T., Reyburn, O., Mandelboim, M., Vales-Gomez, D. M., Davis, L., Pazmany, J. L., Strominger. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells [see comments]. Nature. 386: 514–517, 1997, [CROSSREF]
   Google Scholar
• J., Odeberg, C., Cerboni, H., Browne, K., Karre, E., Moller, E., Carbone, C., Soderberg-Naucler. Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand. J. Immunol.. 55: 149–161, 2002, [CROSSREF]
   Google Scholar
• C. C., Leong, T. L., Chapman, P. J., Bjorkman, D., Formankova, E. S., Mocarski, J. H., Phillips, L. L., Lanier. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: The role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med.. 187: 1681–1687, 1998, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• N. A., Fanger, L., Borges, D., Cosman. The leukocyte immunoglobulin-like receptors (LIRs): A new family of immune regulators. J. Leukoc. Biol.. 66: 231–236, 1999, [CSA]
   Google Scholar
• P., Tomasec, V. M., Braud, C., Rickards, M. B., Powell, B. P., McSharry, S., Gadola, V., Cerundolo, L. K., Borysiewicz, A. J., McMichael, G. W., Wilkinson. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science. 287: 1031, 2000, [CROSSREF]
   Google Scholar
• M., Llano, N., Lee, F., Navarro, P., Garcia, J. P., Albar, D. E., Geraghty, M., Lopez-Botet. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol.. 28: 2854–2863, 1998, [CSA]
   Google Scholar
• M., Ulbrecht, S., Martinozzi, M., Grzeschik, H., Hengel, J. W., Ellwart, M., Pla, E. H., Weiss. Cutting edge: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol.. 164: 5019–5022, 2000
   PubMedGoogle Scholar
• E. C., Wang, B., McSharry, C., Retiere, P., Tomasec, S., Williams, L. K., Borysiewicz, V. M., Braud, G. W., Wilkinson. UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl. Acad. Sci. USA. 99: 7570–7575, 2002, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A. G., Brooks, F., Borrego, P. E., Posch, A., Patamawenu, C. J., Scorzelli, M., Ulbrecht, E. H., Weiss, J. E., Coligan. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol.. 162: 305–313, 1999
   Google Scholar
• J., Kaye, H., Browne, M., Stoffel, T., Minson. The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro. J. Virol.. 66: 6609–6615, 1992, [CSA]
   Google Scholar
• D., Cosman, J., Mullberg, C. L., Sutherland, W., Chin, R., Armitage, W., Fanslow, M., Kubin, N. J., Chalupny. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 14: 123–133, 2001, [CSA]
   PubMed Web of Science ®Google Scholar
• S., Bauer, V., Groh, J., Wu, A., Steinle, J. H., Phillips, L. L., Lanier, T., Spies. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285: 727–729, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. M., Fletcher, H. G., Prentice, J. E., Grundy. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. J. Immunol.. 161: 2365–2374, 1998
   PubMed Web of Science ®Google Scholar
• D. J., Tenney, A. M., Colberg-Poley. Expression of the human cytomegalovirus UL36-38 immediate early region during permissive infection. Virology. 182: 199–210, 1991, [CSA]
   Google Scholar
• E., Reichmann. The biological role of the Fas/FasL system during tumor formation and progression. Semin. Cancer. Biol.. 12: 309–315, 2002, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A., Skaletskaya, L. M., Bartle, T., Chittenden, A. L., McCormick, E. S., Mocarski, V. S., Goldmacher. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA. 98: 7829–7834, 2001, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S., Hu, C., Vincenz, M., Buller, V. M., Dixit. A novel family of viral death effector domain-containing molecules that inhibit both CD-95-and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem.. 272: 9621–9624, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• V. S., Goldmacher, L. M., Bartle, A., Skaletskaya, C. A., Dionne, N. L., Kedersha, C. A., Vater, J. W., Han, R. J., Lutz, S., Watanabe, E. D., Cahir McFarland, E. D., Kieff, E. S., Mocarski, T., Chittenden. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. USA. 96: 12536–12541, 1999, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• D. J., Tenney, A. M., Colberg-Poley. Human cytomegalovirus UL36-38 and US3 immediate-early genes: Temporally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection. J. Virol.. 65: 6724–6734, 1991, [CSA]
   Google Scholar
• W. A., Hayajneh, A. M., Colberg-Poley, A., Skaletskaya, L. M., Bartle, M. M., Lesperance, D. G., Contopoulos-Ioannidis, N. L., Kedersha, V. S., Goldmacher. The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains. Virology. 279: 233–240, 2001, [CSA], [CROSSREF]
   Google Scholar
• A. M., Colberg-Poley, M. B., Patel, D. P., Erezo, J. E., Slater. Human cytomegalovirus UL37 immediate-early regulatory proteins traffic through the secretory apparatus and to mitochondria. J. Gen. Virol.. 81(Pt 7)1779–1789, 2000, [CSA]
   Google Scholar
• J. A., Kerry, A., Sehgal, S. W., Barlow, V. J., Cavanaugh, K., Fish, J. A., Nelson, R. M., Stenberg. Isolation and characterization of a low-abundance splice variant from the human cytomegalovirus major immediate-early gene region. J. Virol.. 69: 3868–3872, 1995, [CSA]
   Google Scholar
• P., Muganda, R., Carrasco, Q., Qian. The human cytomegalovirus IE2 86 kDa protein elevates p53 levels and transactivates the p53 promoter in human fibroblasts. Cell. Mol. Biol. (Noisy-le-grand). 44: 321–331, 1998, [CSA]
   Google Scholar
• K., Tanaka, J. P., Zou, K., Takeda, V. J., Ferrans, G. R., Sandford, T. M., Johnson, T., Finkel, S. E., Epstein. Effects of human cytomegalovirus immediate-early proteins on p53- mediated apoptosis in coronary artery smooth muscle cells. Circulation. 99: 1656–1659, 1999, [CSA]
   PubMedGoogle Scholar
• Y., Yu, J. C., Alwine. Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3′-OH kinase pathway and the cellular kinase Akt. J. Virol.. 76: 3731–3738, 2002, [CSA], [CROSSREF]
   Google Scholar
• S. R., Datta, A., Brunet, M. E., Greenberg. Cellular survival: a play in three Akts. Genes. Dev.. 13: 2905–2927, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A. D., Yurochko, T. F., Kowalik, S. M., Huong, E. S., Huang. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J. Virol.. 69: 5391–5400, 1995, [CSA]
   PubMedGoogle Scholar
• A. D., Yurochko, M. W., Mayo, E. E., Poma, A. S., Baldwin, Jr., E. S., Huang. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters. J. Virol.. 71: 4638–4648, 1997, [CSA]
   PubMedGoogle Scholar